Wegovy Injection (Semaglutide) for Weight Loss

Get Wegovy (semaglutide) prescribed online from ChatWithDr. Wegovy is an FDA-approved GLP-1 receptor agonist for chronic weight management. In the STEP 1 trial (N Engl J Med. 2021;384:989-1002, doi.org/10.1056/NEJMoa2032183), average weight loss was 14.9% of body weight at 68 weeks versus 2.4% with placebo. Weekly injection with dose gradually increased over 16-20 weeks. May be appropriate if BMI is 30+ or 27+ with weight-related conditions. $39.99 consultation with board-certified doctors.

Our Telehealth Services

States We Serve

Available in all 50 US states:

Conditions We Treat

View All Conditions

Resources & Knowledge Hub

More Services

Why Choose ChatWithDr?

Start Your Consultation

Book Now - $39.99